DelangheJR, de BuyzereMLSpeeckaertMM. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Eur J Prev Cardiol 2020; 27: 1331–1332.
2.
RicklinDHajishengallisGYangK, et al.
Complement: A key system for immune surveillance and homeostasis. Nat Immunol2010;
11: 785–797.
3.
PareGChasmanDIKelloggM, et al.
Novel association of ABO histo-blood group antigen with soluble ICAM-1: Results of a genome-wide association study of 6,578 women. PLoS Genet2008;
4: e1000118.
4.
DaiX. ABO blood group predisposes to COVID-19 severity and cardiovascular diseases. Eur J Prev Cardiol. Epub ahead of print 28 April 2020. DOI: 10.1177/2047487320922370
